Medpace Holdings (MEDP) Tops Q4 EPS by 24c ; Offers Guidance

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $2.46, $0.24 better than the analyst estimate of $2.22. Revenue for the quarter came in at $498.4 million versus the consensus estimate of $498.84 million.

GUIDANCE:

Medpace Holdings sees FY2024 revenue of $2.15-2.2 billion, versus the consensus of $2.18 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• Ennis (EBF) Reports In-Line Q1 EPS